Harry Hendrikse

PROF.DR., (Principal Investigator)

Physician, Clinical pharmacology and pharmacy
Full Professor, Amsterdam Neuroscience - Brain Imaging
Full Professor, CCA - Cancer biology and immunology
Full Professor, CCA - Imaging and biomarkers
Full Professor, I&I - Inflammatory diseases

https://orcid.org/0000-0001-8072-5391

If you made any changes in Pure these will be visible here soon.

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1996 2020

79 Article
9 Meeting Abstract
6 Review article
4 Research VU University Amsterdam, graduation VU University Amsterdam
7 More

Repeatability of Quantitative 18F-DCFPyL PET/CT Measurements in Metastatic Prostate Cancer

Jansen, B. H. E., Cysouw, M. C. F., Vis, A. N., van Moorselaar, R. J. A., Voortman, J., Bodar, Y. J. L., Schober, P. R., Hendrikse, N. H., Hoekstra, O. S., Boellaard, R. & Oprea-Lager, D. E., 10 Jan 2020, In : Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Research output: Contribution to journal › Article › Academic › peer-review

ABCG2- and ABCB1 inhibition using supratherapeutic doses of erlotinib: clinical implications in the treatment of CNS metastases

van de Stadt, E. A., Yaqub, M., Bahce, I. & Hendrikse, N. H., 4 Oct 2019, In : Journal of Nuclear Medicine.

Research output: Contribution to journal › Article › Academic › peer-review

Can [F-18]afatinib PET/CT be used in identifying NSCLC patients with different EGFR mutational status: tracer quantification and assessment of tumor uptake

van de Stadt, E., Yaqub, M., Poot, A., Schuit, R., Bahce, I., Smit, E. & Hendrikse, H., 1 May 2019, In : Journal of Nuclear Medicine. 60

Research output: Contribution to journal › Meeting Abstract › Academic

Diagnostics and treatment of diffuse intrinsic pontine glioma: where do we stand?

el-Khouly, F. E., Veldhuijzen van Zanten, S. E. M., Santa-Maria Lopez, V., Hendrikse, N. H., Kaspers, G. J. L., Loizos, G., Sumerauer, D., Nysom, K., Pruunsild, K., Pentikainen, V., Thorarinsdottir, H. K., Rutkauskiene, G., Calvagna, V., Drogosiewicz, M., Dragomir, M., Deak, L., Kitanovski, L., von Bueren, A. O., Kebudi, R., Slavc, I. & 21 othersJacobs, S., Jadrijevic-Cvrlje, F., Entz-Werle, N., Grill, J., Kattamis, A., Hauser, P., Pears, J., Biassoni, V., Massimino, M., Lopez Aguilar, E., Torsvik, I. K., Joao Gil-da-Costa, M., Kumirova, E., Cruz-Martinez, O., Holm, S., Bailey, S., Hayden, T., Thomale, U. W., Janssens, G. O. R., Kramm, C. M. & van Vuurden, D. G., 1 Oct 2019, In : Journal of Neuro-Oncology. 145, 1, p. 177-184 8 p.

Research output: Contribution to journal › Article › Academic › peer-review

Open Access

FEASIBILITY OF A FIRST PEDIATRIC METABOLITE IN SAFETY TESTING PILOT STUDY USING AN ORAL C-14-MIDAZOLAM MICROTRACER.

van Groen, B. D., van Duijn, E., de Vries, A., Mooij, M. G., Windhorst, A. D., Hendrikse, N. H., Tibboel, D., Vaes, W. H. J. & de Wildt, S. N., Mar 2019, In : Clinical Pharmacology & Therapeutics. 105, p. S38-S38

Research output: Contribution to journal › Meeting Abstract › Academic